Antimicrobial resistance in the Netherlands is remaining reasonably stable
Antimicrobial resistance is increasing on a global level. It is difficult to treat infections caused by resistant bacteria.
Updated immunisation recommendation for measles: early vaccination before travel
A number of European countries are currently seeing outbreaks of measles. Before the start of the summer season, RIVM has therefore updated its immunisation recommendation for measles.
iGEM meetup for teams and supervisors
The best synbio projects, including iGEM teams, have one thing in common: cutting edge science in the light of carefully considered societal needs.
Possible health risks due to exposure to chromium-6 at tROM project Tilburg
Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.
Risk of measles outbreaks increases with decreasing vaccination coverage
Vaccination coverage for vaccinations in the Dutch National Vaccination Program (NIP) decreased slightly by about half a percent for the third consecutive year.
Measles epidemic and Salmonella outbreak cost nearly six million euros
The most recent measles epidemic and outbreak of Salmonella Thomson due to smoked salmon have cost 3.9 and 1.7 million euros, respectively.
CAESAR annual report 2014
The World Health Organization (WHO) published its first CAESAR annual report 2014.
No more complementary vaccinations against measles for children aged six months
The measles epidemic, the first case of which occurred in the Netherlands in May 2013, is coming to an end.